Cantor Colburn LLP’s Pharmaceutical Practice Group handles litigation, patent prosecution, inter partes reviews and other Patent Office review proceedings, opinions, landscapes, licensing, portfolio management and more to pharmaceutical and life science clients worldwide. Our team is experienced in a wide variety of technologies, including chemistry, biochemistry, organic chemistry and pharmaceuticals, and has represents clients in Hatch-Waxman and pharmaceutical litigation matters. We secure intellectual property rights for drug discovery companies and also defend generic pharmaceutical companies against allegations of patent infringement, including those that arise out of ANDA filings. Cantor Colburn provides guidance to clients during the preparation of ANDAs, performing opinion work, and preparing Paragraph IV letters. Cantor Colburn is the #4 U.S. patent law firm and the #1 firm for overcoming Mayo/Myriad rejections.